Kamada (KMDA) Payables (2012 - 2026)
Kamada (KMDA) posted quarterly Payables of $21.9 million for Q1 2026, down 11.73% year-on-year from $24.9 million in Q1 2025, and down 5.61% on a QoQ basis from $23.2 million in Q4 2025.
Kamada (KMDA) Payables (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Payables for 15 consecutive years, with $21.9 million the latest figure, recorded in Q1 2026.
- Quarterly Payables fell 11.73% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (down 11.73% YoY) and the FY2025 annual result came in at $23.2 million, down 16.2% from the prior year.
- Payables retreated to $21.9 million in Q1 2026 per KMDA's latest filing, from $23.2 million in the prior quarter.
- Over the last five years, Payables for KMDA reached as high as $37.4 million in Q4 2022 and fell as low as $30654.0 in Q1 2023.
- A 5-year average of $20.2 million and a median of $22.4 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables tumbled 99.82% — and 2024, when it jumped 53700.48%.
- Year by year, Payables stood at $37.4 million in 2022, then plunged by 33.61% to $24.8 million in 2023, then increased by 11.82% to $27.7 million in 2024, then slipped by 16.2% to $23.2 million in 2025, then decreased by 5.61% to $21.9 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $21.9 million, $23.2 million, and $24.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 21.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.94 Mn |
| Dec 31, 2025 | 23.24 Mn |
| Sep 30, 2025 | 24.88 Mn |
| Jun 30, 2025 | 25.08 Mn |
| Mar 31, 2025 | 24.85 Mn |
| Dec 31, 2024 | 27.74 Mn |
| Sep 30, 2024 | 14.79 Mn |
| Jun 30, 2024 | 19.53 Mn |
| Mar 31, 2024 | 16.49 Mn |
| Dec 31, 2023 | 24.80 Mn |
| Sep 30, 2023 | 12.81 Mn |
| Jun 30, 2023 | 32.41 Mn |
| Mar 31, 2023 | 30,654.00 |
| Dec 31, 2022 | 37.36 Mn |
| Sep 30, 2022 | 35,063.00 |
| Jun 30, 2022 | 22.40 Mn |
| Mar 31, 2022 | 15.41 Mn |
| Dec 31, 2021 | 27.74 Mn |
| Sep 30, 2021 | 19.06 Mn |
| Jun 30, 2021 | 18.01 Mn |